Top 10 Best Oncology Billing Companies in the USA
Explore the top 10 best oncology billing companies in the US for 2026, including MBW RCM. Learn how specialized oncology billing partners help reduce denials, improve reimbursements, and optimize revenue cycle performance for cancer care practices.
How to Conduct an Internal Mock Audit of Your Oncology Practice Billing and Coding
Conducting an internal mock audit is critical for oncology practices. This step-by-step guide explains how to improve coding accuracy, reduce denials, and secure compliance for high-cost oncology claims. Protect your revenue cycle with regular billing and coding audits.
Top 10 Questions to Ask Your Oncology Billing Vendor About Prior Authorizations
Prior authorizations (PAs) are one of the biggest hurdles in oncology billing. Asking the right questions when choosing a billing partner ensures faster approvals, fewer denials, and stronger revenue cycle performance. Here are the 10 essential questions to evaluate your oncology billing vendor’s PA process.
Is Your RCM Partner Failing? Key Metrics for Evaluating Best Oncology Billing Companies
Is your RCM partner underperforming? A best oncology billing companies evaluation helps oncology practices measure AR, denials, and appeal outcomes. Learn which metrics to track and how to ensure billing partners deliver consistent revenue performance.
Specialized Hematology-Oncology Billing: Why Generic Services Can’t Handle Complex Drug Claims
Oncology practices rely heavily on high-cost drug claims, making billing accuracy critical. This blog explains why generic billing services fail and how specialized hematology-oncology billing—through expertise in J-Codes, modifiers, prior authorization, and payer rules—ensures full reimbursement and protects your revenue cycle.
How to Appeal Justified Oncology Denials: Stop Writing Off Revenue (Appeals Strategy)
Too many oncology practices write off justified denials as lost revenue. This guide outlines a proven, step-by-step strategy for oncology billing appeals—covering prior authorizations, J-Codes, LCD/NCD compliance, and underpayment recovery to protect margins and improve oncology RCM outcomes.